山河药辅
(300452)
| 流通市值：23.24亿 | | | 总市值：29.16亿 |
| 流通股本：1.87亿 | | | 总股本：2.34亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 237,688,540.94 | 839,259,534.36 | 640,355,017.44 | 452,943,330.41 |
| 营业收入 | 237,688,540.94 | 839,259,534.36 | 640,355,017.44 | 452,943,330.41 |
| 二、营业总成本 | 189,620,354.92 | 685,094,492.59 | 515,538,731.29 | 360,280,032.55 |
| 营业成本 | 158,433,501.01 | 573,289,159.1 | 438,613,930.9 | 308,516,726.23 |
| 税金及附加 | 2,554,003.96 | 6,204,567.36 | 4,642,994.3 | 2,760,679.3 |
| 销售费用 | 7,569,045.89 | 28,540,224.18 | 19,619,668.2 | 13,443,034.58 |
| 管理费用 | 6,528,396.98 | 32,095,987.39 | 20,690,248.88 | 13,229,692.11 |
| 研发费用 | 11,783,747.62 | 41,952,772.69 | 30,674,826.71 | 22,230,727.1 |
| 财务费用 | 2,751,659.46 | 3,011,781.87 | 1,297,062.3 | 99,173.23 |
| 其中:利息费用 | 3,296,396.46 | 4,298,466.84 | 2,468,253.41 | 1,065,663.06 |
| 其中:利息收入 | 317,819.81 | 1,306,317.02 | 1,039,251.33 | 608,639.2 |
| 加:公允价值变动收益 | 2,670,735.94 | 8,513,644.41 | 7,155,419.96 | 3,288,440.9 |
| 加:投资收益 | 3,745,773.2 | 10,538,516.06 | 3,862,196.5 | 2,715,527.74 |
| 资产处置收益 | -129,691.8 | -13,840.49 | -14,107.7 | 1,784.19 |
| 资产减值损失(新) | - | -988,545.87 | - | - |
| 信用减值损失(新) | 2,606.72 | -66,001.36 | -2,150.04 | -16,975.59 |
| 其他收益 | 2,815,061.43 | 13,295,507.73 | 5,864,989.24 | 3,861,004.38 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 57,172,671.51 | 185,444,322.25 | 141,682,634.11 | 102,513,079.48 |
| 加:营业外收入 | 111,182.31 | 670,910.55 | 492,238.27 | 313,994.86 |
| 减:营业外支出 | 36,352.38 | 295,759.62 | 36,290.33 | 58,807.7 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 57,247,501.44 | 185,819,473.18 | 142,138,582.05 | 102,768,266.64 |
| 减:所得税费用 | 6,729,415.64 | 21,197,006.51 | 16,449,085.3 | 11,885,513.02 |
| 六、净利润 | 50,518,085.8 | 164,622,466.67 | 125,689,496.75 | 90,882,753.62 |
| 持续经营净利润 | 50,518,085.8 | 164,622,466.67 | 125,689,496.75 | 90,882,753.62 |
| 归属于母公司股东的净利润 | 49,815,076 | 161,535,015.82 | 123,531,091.5 | 88,329,256.21 |
| 少数股东损益 | 703,009.8 | 3,087,450.85 | 2,158,405.25 | 2,553,497.41 |
| (一)基本每股收益 | 0.21 | 0.69 | 0.53 | 0.38 |
| (二)稀释每股收益 | 0.21 | 0.67 | 0.53 | 0.38 |
| 九、综合收益总额 | 50,518,085.8 | 164,622,466.67 | 125,689,496.75 | 90,882,753.62 |
| 归属于母公司股东的综合收益总额 | 49,815,155.08 | 161,535,015.82 | 123,531,091.5 | 88,329,256.21 |
| 归属于少数股东的综合收益总额 | 702,930.72 | 3,087,450.85 | 2,158,405.25 | 2,553,497.41 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-25 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |